38
Participants
Start Date
September 4, 2024
Primary Completion Date
January 9, 2025
Study Completion Date
September 22, 2025
IBI311 (20 mg)
Arm 4: 10 mg/kg IBI311 on Day 1, followed by 20 mg/kg IBI311 from week 3 to week 21, Q3W.
IBI311 (3-20 mg)
Arm 2: 3 mg/kg IBI311 from day 1 to week 9, Q3W, followed by 20 mg/kg IBI311 from week 12 to week 21, Q3W.
IBI311 (10 mg)
Arm 3: 10 mg/kg IBI311 from day 1 to week 21, Q3W.
IBI311 (3-10mg/kg)
Arm 1: 3 mg/kg IBI311 from day 1 to week 9, Q3W, followed by 10 mg/kg IBI311 from week 12 to week 21, Q3W.
Innovent Biologics (Suzhou) Co. Ltd, Suzhou
Innovent Biologics (Suzhou) Co. Ltd.
INDUSTRY